Background Diabetes is presently classified into two main forms, type 1 and type 2 diabetes,
but type 2 diabetes in particular is highly heterogeneous. A refined classification could …

Type 2 diabetes (T2D) is a complex and heterogeneous disease which affects millions of
people worldwide. The classification of diabetes is at an interesting turning point and there …

Betatrophin has recently been described as a key hormone to stimulate beta-cell mass
expansion in response to insulin resistance and obesity in mice. The finding has generated an …

Aims/hypothesis Excessive weight is a risk factor for type 2 diabetes, but its role in the
promotion of autoimmune diabetes is not clear. We investigated the risk of latent autoimmune …

OBJECTIVE Type 2 diabetes (T2D) was recently reclassified into severe insulin-deficient
diabetes (SIDD), severe insulin-resistant diabetes (SIRD), mild obesity-related diabetes (MOD), …

Metformin is the first-line pharmacotherapy for managing type 2 diabetes (T2D). However,
many patients with T2D do not respond to or tolerate metformin well. Currently, there are no …

Objective Sweetened beverage intake is associated with increased risk of type 2 diabetes,
but its association with autoimmune diabetes is unclear. We aimed to investigate sweetened …

Aims To determine the prevalence and incidence of Type 2 diabetes and its complications
in Uppsala county, Sweden between 1996 and 2003. Methods Retrospective population‐…

The app-based COVID Symptom Study was launched in Sweden in April 2020 to contribute
to real-time COVID-19 surveillance. We enrolled 143,531 study participants (≥18 years) …

AIMS: The purpose of this study was to investigate the time between the start of OAD
treatment and the initiation of insulin therapy and to identify the factors associated with insulin …